Gwen A. Fyfe Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gwen A. Fyfe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gwen A. Fyfe. Gwen A. Fyfe is a Director in PHARMACYCLICS INC ($PCYC) and a Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and a in ARRAY BIOPHARMA INC ($ARRY) and a Director in ARRAY BIOPHARMA INC ($ARRY) and a Director in Cascadian Therapeutics, Inc. ($ONTY).
Address: 995 EAST ARQUES AVENUE SUNNYVALE 94085 CA
Companies in which Gwen A. Fyfe is an Insider
ARRAY BIOPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gwen A. Fyfe: Director
Holdings: 5,000 shares
Current Value: $52,650
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Gwen A. Fyfe: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gwen A. Fyfe: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2015
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PHARMACYCLICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gwen A. Fyfe: Director
Holdings: 0 shares
Latest Transaction: Dec 13 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gwen A. Fyfe
Sentiment: All, ARRY, CASC, INFI, PCYC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 4.36 | 20,000 | 87,200 | 0 |